Innovations to Improve Vaccine Equity

November 13, 2018

Over the last decade, there has been a mobilization to ensure low-income countries are able to purchase vaccines and expedite the introduction of new products into their immunization systems. While the effort has paid off in many areas, coverage rates have stagnated in recent years. To explore the way forward, the CSIS Global Health Policy Center is hosting a half-day conference focusing on novel approaches and innovative ideas for achieving more equitable vaccine delivery worldwide.

Speakers will focus on specific strategies, technologies, and data needed to narrow disparities in vaccine coverage and overcome barriers to access in disordered and fragile settings. The conference will provide a forum for robust conversation around the need for continued U.S. and multilateral engagement through vaccine purchases and additional investments, to improve immunization rates and strengthen immunization systems globally. Additionally, the conference will highlight how immunizations fit within a priority area of the newly launched CSIS Commission on Strengthening America’s Health Security.

This event will be live webcast from this page.

You May Also Like

VPPN Market Intelligence Series: Europe and Central Asia countries tell us how they leverage market intelligence for their vaccine procurement strategy

The Vaccine Procurement Practitioners Network (VPPN) will conclude their series on market intelligence with a third and final webinar that will take place on Thursday, 5 December 2024, from 1pm to 2pm GMT+1, in English, Russian and French. This webinar will focus on how market intelligence can help with understanding vaccine markets to inform a procurement … Read More

2025 Advanced Course of Vaccinology (ADVAC)

ADVAC is a two-week training program which delivers a comprehensive overview of the various aspects of vaccinology. This advanced Course is for scientists and decision-makers involved in vaccine development, in the elaboration of new vaccination strategies or in policy decisions related to the introduction of new vaccines in public health programmes, at national or international … Read More